Oslo, Norway, 25 June 2013: Photocure ASA (OSE: PHO), a specialty pharmaceutical company focused on photodynamic technologies in dermatology and cancer, is pleased to note the statement sent out by US Congressman Tom Reed today on his introduction of a new legislation to ensure that senior patients have access to the most up-to-date, state-of-the-art cancer treatment technology.
Congressman Tom Reed’s full statement can be found here: http://reed.house.gov/press-releases.
For further information, please contact:
President & CEO Kjetil Hestdal
Tel: + 47 913 19 535, Email: firstname.lastname@example.org
CFO Erik Dahl
Tel: +47 50 55 000, Email: email@example.com
Mary Clark, Hollie Vile, Supriya Mathur
Tel: +44 20 3440 5653, Email: firstname.lastname@example.org